3. Borger M.A., Alam A., Murphy P.M., (2006) et al: Chronic ischemic mitral regurgitation: Repair, replace or rethink?. Ann Thorac Surg; 81:1153.10.1016/j.athoracsur.2005.08.08016488757
4. Cleve, Jayne; McCulloch, Marti L. “Conducting a Cardiac Ultrasound Examination”, Echocardiography, Springer International Publishing, (2018), pp. 33–4210.1007/978-3-319-71617-6_2
7. Popescu B., Beladan C., Ticulescu R. (2011) Evaluarea Doppler a functiei ventriculului stang in Popescu B si Ginghina C : Ecocardiografia Doppler, Bucuresti, Ed Medicala, 69-81
8. Smith-Bindman R, Miglioretti DL, Johnson E, Lee C, Feigelson HS, Flynn M. Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996-2010. JAMA. 2012 Jun 13;307(22):2400-910.1001/jama.2012.5960385987022692172
9. Bellenger, Burgess, Ray M SG, et al (2000) Comparison of left ventricular ejection fraction and volumes in heart failure by two-dimensional radionuclide ventriculography, echocardiography and cardiovascular magnetic resonance: Are they interchangeable? Eur Heart ; 21: 1387 17.10.1053/euhj.2000.201110952828
10. My VM, Axel L. Advances in MRI tagging techniques for determining regional myocardialstrain. Cardiol Rep; 2006: 8:-53.10.1007/s11886-006-0011-416507237
11. Schwitter, J., Array of: cardiac ischemia and assessmant of viability: of cardiovascular magnetic resonance. Eur Heart J 32;2011: 799-8110.1093/eurheartj/ehq481306938721398645
12. Rutz A.K., Manka R., Kozerke S., Roas S., Boesiger P., Schwitter J. Left ventricular dyssynchrony in patients with left bundle branch block and patients after myocardial infarction: integration of mechanics and viability by cardiac magnetic resonance. Eur Heart J, (2009) 30:2117 – 212710.1093/eurheartj/ehp21219477875
13. Smanio PE, Buchpiguel CA. Timerman A, Bertolami MC, Ferreira FM. Manual de cardiologia. São Paulo: Atheneu; 2012. Medicina Nuclear: Princípios gerais, indicações e interpretação; pp. 781–789
14. Bogaert J, Gheysens O, Dymarkowski S, Goetschalckx K. Comprehensive evaluation of hibernating myocardium: use of noninvasive imaging. J Thorac Imaging. 2014; 29(3):134-4610.1097/RTI.000000000000006924468709
15. Schuster A, Morton G, Chiribiri A, Perera D. Imaging in the Management of Ischemic Cardiomyopathy. JACC, 2012;59 (4):359–7010.1016/j.jacc.2011.08.07622261158
17. Schuster A, Morton G, Chiribiri A, Perera D. Imaging in the Management of Ischemic Cardiomyopathy. JACC, 2012;59 (4):359–7010.1016/j.jacc.2011.08.07622261158
19. Lima GL, Camara de Caralho FP. Ischemic left ventricle systolic dysfunction: An evidence-based approach in diagnostic tools and therapeutics. Rev Assoc Med BraS 2017; 63(9):793-80010.1590/1806-9282.63.09.79329239459
20. Berman D.S., Hachamovitch R., Shaw L.J., et al. Roles of nuclear cardiology, cardiac computed tomography, and cardiac magnetic resonance: noninvasive risk stratification and a conceptual framework for the selection of noninvasive imaging tests in patients with known or suspected coronary artery disease. Journal of Nuclear Medicine, 47 (2006), pp. 1107-1118
21. Yoshinaga K., Chow B.J., Williams K., et al. What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography? Journal of the American College of Cardiology, 48 (2006), pp. 1029-103910.1016/j.jacc.2006.06.02516949498